Hypopituitarism Clinical Trial
Official title:
Double-blind Trial Investigating the Safety and Efficacy of the Inhibitor Anastrozole (ARIMIDEX) in Delaying Epiphyseal Fusion and Increasing Height Potential of Adolescent Males With Growth Hormone (GH) Deficiency
The purpose of this study is to see if Arimidex, an aromatase inhibitor, can delay epiphyseal fusion and increase predicted adult height in boys who are growth hormone deficient, in puberty, and who are taking growth hormone. This is a double blind, placebo controlled 3 year trial.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02871986 -
Pubertal Induction in Individuals With Hypogonadism
|
N/A | |
Completed |
NCT00851942 -
Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test
|
Phase 4 | |
Completed |
NCT00507104 -
Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)
|
||
Completed |
NCT01088399 -
A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults
|
N/A | |
Completed |
NCT00027430 -
Androgen Replacement Therapy in Women With Hypopituitarism
|
N/A | |
Recruiting |
NCT04897802 -
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
|
Phase 4 | |
Not yet recruiting |
NCT06014398 -
Improving Survivorship and Health-related Quality of Life in Patients With Primary Brain Tumours
|
N/A | |
Recruiting |
NCT04121780 -
Growth Hormone Replacement Therapy for Retried Professional Football Players
|
Phase 2 | |
Not yet recruiting |
NCT01666964 -
Hormone Deficiency After Brain Injury During Combat
|
N/A | |
Completed |
NCT01028742 -
Posttraumatic Hypopituitarism - Incidence, Predictors and Test Validity
|
N/A | |
Completed |
NCT00139945 -
Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient Patients
|
N/A | |
Completed |
NCT05206149 -
Stimulation Test With Intranasal Glucagon for Corticotroph, Somatotroph and Antidiuretic Axes
|
Phase 4 | |
Completed |
NCT05188131 -
Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium
|
Phase 4 | |
Not yet recruiting |
NCT03708523 -
Next Day Growth Hormone Predicting Pituitary Function After Adenomectomy
|
||
Completed |
NCT01007071 -
Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency
|
Phase 3 | |
Completed |
NCT00080483 -
Testosterone and Growth Hormone for Bone Loss in Men
|
Phase 2 | |
Completed |
NCT01009905 -
An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)
|
N/A | |
Completed |
NCT01209416 -
The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin
|
N/A | |
Completed |
NCT04902235 -
Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)
|
Phase 4 | |
Not yet recruiting |
NCT06326853 -
Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models
|